Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma
Clinics in Liver Disease · 2023
DOI: 10.1016/j.cld.2023.01.019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2023. Verfasst von Saleh A Alqahtani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, MD, USA; Liver Transplant Center, King Faisal Specialist Hospital a…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Non-alcoholic Fatty Liver Disease, Liver Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide and represents a significant cause of cirrhosis and hepatocellular carcinoma (HCC). Almost 20% of patients with NAFLD and advanced fibrosis develop cirrhosis, of which 20% can progress to decompensated liver stage. Although patients with cirrhosis or fibrosis continue to have a high risk for HCC progression, growing evidence shows that NAFLD-HCC can develop even in the absence of cirrhosis. Current evidence characterizes NAFLD-HCC primarily as a condition with late presentation, lower response to curative therapy, and poor prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, MD, USA; Liver Transplant Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Electronic address: salqaht1…
- Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
- School of Medicine, College of Medicine, National Sun Yat-Sen University, Kaohsiung, Taiwan; Hepatitis Research Center, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Hepatobiliary Section, Depart…
Zitieren
APA
Alqahtani, S. A., Chan, W. K., & Yu, M. L. (2023). Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma. Clinics in Liver Disease. https://doi.org/10.1016/j.cld.2023.01.019
Vancouver
Alqahtani SA, Chan WK, Yu ML. Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma. Clinics in Liver Disease. 2023. doi:10.1016/j.cld.2023.01.019
BibTeX
@article{Alqahtani2023,
author = {Alqahtani, Saleh A and Chan, Wah-Kheong and Yu, Ming-Lung},
title = {Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma},
journal = {Clinics in Liver Disease},
year = {2023},
doi = {10.1016/j.cld.2023.01.019}
}
EUVIMED